Skip navigation
Agenda

Uncover the Risks Associated with Anti-Bribery and Anti-Corruption, Data Privacy and HCP Engagement

March 13-14, 2018
  • Shanghai, China

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, 13 MARCH 2018

7:15

Conference Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

Ethics and Compliance as a Strategic Business Partner

8:30

CASE STUDY Shaping a Compliant Culture in Your Business

Li Yan
Senior Compliance Manager
Novo Nordisk

9:15

PANEL DISCUSSION Transform the Compliance Mindset at Different Management Levels

MODERATOR:

Seth Yu
Legal Director, Global Investigations, Office of General Counsel
MSD Merck

PANELISTS:

Rhys Tee
Director, Compliance and Privacy, ASPAC
Ortho Clinical Diagnostics

Christine Ng
Head, Ethics & Compliance Officer, Greater China
GlaxoSmithKline

Serene Shi
Ethics and Business Integrity Business Partner
Sanofi

10:15

Networking and Refreshment Break

10:45

Building a Positive Business Impact through an Ethical Culture

Ela Bochenek, JD
Assistant Dean Graduate & Professional Education
Seton Hall Law School

Anti-Bribery and Anti-Corruption (ABAC)

11:30

FACILITATED DISCUSSION Compliance Controls and Practices Unique to the China Life
Sciences Industry

Hussein Al-Shawaf
Compliance & Ethics Manager
Denstply Sirona

12:15

Networking Luncheon

13:30

Building a Healthy Vendor and Third-Party Program to Address Your Compliance Issues

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

M&A and Joint Ventures

14:15

Identify Risk Factors in Mergers, Acquisitions and Joint Ventures

Kent Kedl
Senior Partner
Control Risks

15:00

Networking and Refreshment Break

Monitoring and Investigations

15:30

IN-DEPTH OVERVIEW Examine Current and Emergent Risk Zones for Monitors

Arvind Nambiar Reventhiran
Regional Compliance Monitor
Sandoz

15:30

The WeChat Effect — Understanding the Compliance Risks of Instant Messaging and Social Media Apps

Brian Burke
Partner
Shearman & Sterling LLP

17:00

Close of Day One

Networking, Wine and Cheese Reception HOSTED BY: Ernst & Young

DAY TWOWEDNESDAY, 14 MARCH 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

8:45

Improving the Investigations Process for Better Results

Eric Carlson
Partner
Covington & Burling (Shanghai)

Transparency

9:30

Ride the Global Aggregate Spend and Transparency Wave — Compare and Contrast the Latest Regulations and Disclosure Process

Albert van Maaren
Regional Compliance Officer Healthcare APAC, Group Compliance
Merck KGaA

10:15

Networking and Refreshment Break

HCP Risk Management

10:45

Transparency Panel Discussion

MODERATOR:

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

PANELISTS:

Hiroyuki Fukumori
Director, Corporate Compliance
Taiho Pharmaceutical Co., Ltd.

Albert van Maaren
Regional Compliance Officer Healthcare APAC, Group Compliance
Merck KGaA

Asia-Pacific Anti-Trust and Competition Law

11:30

Evaluate the Risks Associated with HCP Engagements

Joyce Wong
Managing Director, Polaris Asia Pacific;
Former General Manager, Eli Lilly Asia Inc (Hong Kong)

12:15

Networking Luncheon

Cybersecurity and Data Protection

13:15

CO-PRESENTATION Asia-Pacific Data Protection Regulations — Trends and Recent Developments

Rhys Tee
Director, Compliance and Privacy, ASPAC
Ortho Clinical Diagnostics

Carly Ramsey
Associate Director
Control Risks

R&D and Clinical Compliance

14:00

Risk Planning and Mitigation during R&D and the Clinical Trial Lifecycle

Steve Zhao
R&D Ethics & Compliance Director
GlaxoSmithKline

14:45

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE TUESDAY, 13 MARCH 2018

7:15

Conference Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

Ethics and Compliance as a Strategic Business Partner

8:30

CASE STUDY Shaping a Compliant Culture in Your Business

Li Yan
Senior Compliance Manager
Novo Nordisk

9:15

PANEL DISCUSSION Transform the Compliance Mindset at Different Management Levels

MODERATOR:

Seth Yu
Legal Director, Global Investigations, Office of General Counsel
MSD Merck

PANELISTS:

Rhys Tee
Director, Compliance and Privacy, ASPAC
Ortho Clinical Diagnostics

Christine Ng
Head, Ethics & Compliance Officer, Greater China
GlaxoSmithKline

Serene Shi
Ethics and Business Integrity Business Partner
Sanofi

10:15

Networking and Refreshment Break

10:45

Building a Positive Business Impact through an Ethical Culture

Ela Bochenek, JD
Assistant Dean Graduate & Professional Education
Seton Hall Law School

Anti-Bribery and Anti-Corruption (ABAC)

11:30

FACILITATED DISCUSSION Compliance Controls and Practices Unique to the China Life
Sciences Industry

Hussein Al-Shawaf
Compliance & Ethics Manager
Denstply Sirona

12:15

Networking Luncheon

13:30

Building a Healthy Vendor and Third-Party Program to Address Your Compliance Issues

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

M&A and Joint Ventures

14:15

Identify Risk Factors in Mergers, Acquisitions and Joint Ventures

Kent Kedl
Senior Partner
Control Risks

15:00

Networking and Refreshment Break

Monitoring and Investigations

15:30

IN-DEPTH OVERVIEW Examine Current and Emergent Risk Zones for Monitors

Arvind Nambiar Reventhiran
Regional Compliance Monitor
Sandoz

15:30

The WeChat Effect — Understanding the Compliance Risks of Instant Messaging and Social Media Apps

Brian Burke
Partner
Shearman & Sterling LLP

17:00

Close of Day One

Networking, Wine and Cheese Reception HOSTED BY: Ernst & Young

DAY TWOWEDNESDAY, 14 MARCH 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

8:45

Improving the Investigations Process for Better Results

Eric Carlson
Partner
Covington & Burling (Shanghai)

Transparency

9:30

Ride the Global Aggregate Spend and Transparency Wave — Compare and Contrast the Latest Regulations and Disclosure Process

Albert van Maaren
Regional Compliance Officer Healthcare APAC, Group Compliance
Merck KGaA

10:15

Networking and Refreshment Break

HCP Risk Management

10:45

Transparency Panel Discussion

MODERATOR:

Geert van Gansewinkel
Managing Partner
Polaris Europe and Asia-Pacific

PANELISTS:

Hiroyuki Fukumori
Director, Corporate Compliance
Taiho Pharmaceutical Co., Ltd.

Albert van Maaren
Regional Compliance Officer Healthcare APAC, Group Compliance
Merck KGaA

Asia-Pacific Anti-Trust and Competition Law

11:30

Evaluate the Risks Associated with HCP Engagements

Joyce Wong
Managing Director, Polaris Asia Pacific;
Former General Manager, Eli Lilly Asia Inc (Hong Kong)

12:15

Networking Luncheon

Cybersecurity and Data Protection

13:15

CO-PRESENTATION Asia-Pacific Data Protection Regulations — Trends and Recent Developments

Rhys Tee
Director, Compliance and Privacy, ASPAC
Ortho Clinical Diagnostics

Carly Ramsey
Associate Director
Control Risks

R&D and Clinical Compliance

14:00

Risk Planning and Mitigation during R&D and the Clinical Trial Lifecycle

Steve Zhao
R&D Ethics & Compliance Director
GlaxoSmithKline

14:45

Close of Conference